Phase II Trial of Methylglyoxal Bis-Guanylhydrazone (MGBG) in Refractory Small Cell Lung Cancer

Investigational New Drugs - Netherlands
doi 10.1007/bf00171989
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature